Beijing Aosaikang Pharmaceutical Co., Ltd. (SHE:002755)

China flag China · Delayed Price · Currency is CNY
16.21
+0.96 (6.30%)
Apr 29, 2026, 3:04 PM CST
-13.96%
Market Cap 14.15B
Revenue (ttm) 1.78B
Net Income (ttm) 236.60M
Shares Out 928.16M
EPS (ttm) 0.25
PE Ratio 57.07
Forward PE n/a
Dividend 0.12 (0.79%)
Ex-Dividend Date n/a
Volume 25,570,818
Average Volume 22,611,694
Open 15.92
Previous Close 15.25
Day's Range 15.40 - 16.40
52-Week Range 13.38 - 29.00
Beta 0.16
RSI 55.98
Earnings Date Apr 29, 2026

About SHE:002755

Beijing Aosaikang Pharmaceutical Co., Ltd. researches, develops, manufactures, markets, and sells pharmaceuticals, fine chemicals, and health-care products in China. It offers proton pump inhibitor injections and oncology medicines, as well as APIs. The company provides its products in oncology, antibiotic, and other areas. Beijing Aosaikang Pharmaceutical Co., Ltd. was founded in 2003 and is based in Nanjing, China. [Read more]

Sector Healthcare
Founded 2003
Employees 988
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002755
Full Company Profile

Financial Performance

In 2025, SHE:002755's revenue was 1.78 billion, an increase of 0.08% compared to the previous year's 1.78 billion. Earnings were 236.60 million, an increase of 47.60%.

Financial Statements

News

There is no news available yet.